[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)] [Notices] [Page 29057] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2017-13408] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Intent To Grant an Exclusive License of U.S. Government-Owned Patents AGENCY: Department of the Army, DoD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. Patent 7,956,086, issued June 7, 2011, entitled, ``Methods for the Formulation and Manufacture of Artesunic Acid for Injection'' to Amivas, LLC, having its principal place of business at 8403 Colesville Road, Suite 630, Silver Spring, Maryland 20910. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry Datlof, Office of Research & Technology Applications, (301) 619-0033. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619- 7808, both at telefax (301) 619-5034. SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2017-13408 Filed 6-26-17; 8:45 am] BILLING CODE 5001-03-P